These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1225 related articles for article (PubMed ID: 7774641)

  • 21. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.
    Nakagomi H; Dolcetti R; Bejarano MT; Pisa P; Kiessling R; Masucci MG
    Int J Cancer; 1994 Apr; 57(2):240-4. PubMed ID: 8157362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.
    Avila-Carino J; Torsteinsdottir S; Bejarano MT; Klein G; Klein E; Masucci MG
    Cell Immunol; 1988 Dec; 117(2):303-11. PubMed ID: 2848629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
    Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
    Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line.
    Khanna R; Burrows SR; Argaet V; Moss DJ
    Int Immunol; 1994 Apr; 6(4):639-45. PubMed ID: 7517178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
    Wang F; Li X; Annis B; Faustman DL
    Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.
    Finke J; Fritzen R; Ternes P; Trivedi P; Bross KJ; Lange W; Mertelsmann R; Dölken G
    Blood; 1992 Jul; 80(2):459-69. PubMed ID: 1378321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
    Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
    Vockerodt M; Tesch H; Kube D
    Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
    Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.
    Destro F; Sforza F; Sicurella M; Marescotti D; Gallerani E; Baldisserotto A; Marastoni M; Gavioli R
    Immunology; 2011 May; 133(1):105-14. PubMed ID: 21342184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.
    Khanna R; Burrows SR; Moss DJ; Silins SL
    J Virol; 1996 Aug; 70(8):5357-62. PubMed ID: 8764046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
    Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
    Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line.
    Zhang Q; Brooks L; Busson P; Wang F; Charron D; Kieff E; Rickinson AB; Tursz T
    Eur J Immunol; 1994 Jun; 24(6):1467-70. PubMed ID: 8206105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression.
    Kienzle N; Sculley TB; Poulsen L; Buck M; Cross S; Raab-Traub N; Khanna R
    J Virol; 1998 Aug; 72(8):6614-20. PubMed ID: 9658107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination.
    Walter J; Schirrmacher V; Mosier D
    Int J Cancer; 1995 May; 61(3):363-9. PubMed ID: 7537255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition.
    Lee SP; Constandinou CM; Thomas WA; Croom-Carter D; Blake NW; Murray PG; Crocker J; Rickinson AB
    Blood; 1998 Aug; 92(3):1020-30. PubMed ID: 9680372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ; Crawford DH; Thomas JA
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
    Gregory CD; Murray RJ; Edwards CF; Rickinson AB
    J Exp Med; 1988 Jun; 167(6):1811-24. PubMed ID: 2898508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.